bosentan anhydrous has been researched along with pituitrin in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brain, SD; Lawrence, E | 1 |
| Balakrishnan, SM; Gopalakrishnan, V; McNeill, JR | 1 |
| Champion, HC; Estrada, LN; Estrada, LS; Filep, JG; Kadowitz, PJ | 1 |
| Gopalakrishnan, V; McNeill, JR; Yu, M | 1 |
| Dhalla, NS; Rehsia, NS | 1 |
1 review(s) available for bosentan anhydrous and pituitrin
| Article | Year |
|---|---|
Potential of endothelin-1 and vasopressin antagonists for the treatment of congestive heart failure.
Topics: Angiotensin II; Animals; Antidiuretic Agents; Antihypertensive Agents; Benzazepines; Biomarkers; Bosentan; Catecholamines; Drug Therapy, Combination; Endothelin-1; Heart Failure; Humans; Peptides, Cyclic; Renin-Angiotensin System; Sulfonamides; Sympathetic Nervous System; Tolvaptan; Treatment Outcome; Vasopressins | 2010 |
4 other study(ies) available for bosentan anhydrous and pituitrin
| Article | Year |
|---|---|
Effect of BQ-123 and Ro 47-0203 (bosentan) on endothelin-induced vasoconstriction in the rat skin.
Topics: Animals; Bosentan; Endothelin Receptor Antagonists; Endothelins; Injections, Intradermal; Male; Peptides, Cyclic; Phenylephrine; Rats; Rats, Wistar; Regional Blood Flow; Skin; Sulfonamides; Vasoconstriction; Vasopressins | 1994 |
Endothelin contributes to the hemodynamic effects of vasopressin in spontaneous hypertension.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Cardiac Output; Dose-Response Relationship, Drug; Endothelin-1; Heart Rate; Hemodynamics; Hypertension; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sulfonamides; Vasoconstrictor Agents; Vasopressins | 1997 |
Analysis of effects of bosentan (Ro 47-0203), a nonpeptide endothelin ETA/ETB receptor antagonist, in the hind-limb vascular bed of the cat.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Bosentan; Cats; Endothelin Receptor Antagonists; Endothelin-1; Hindlimb; Receptor, Endothelin B; Receptors, Endothelin; Sulfonamides; Vasoconstriction; Vasodilation; Vasopressins | 1998 |
Role of endothelin and vasopressin in DOCA-salt hypertension.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Bosentan; Cardiac Output; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Hypertension; Injections, Intravenous; Male; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors; Vascular Resistance; Vasopressins | 2001 |